date,title,source
Nov-01-18,Constellation Pharmaceuticals Receives FDA Fast Track Designation for CPI-0610 in Treatment of Myelofibrosis,GlobeNewswire
Nov-08-18,Constellation Pharmaceuticals Announces Third-Quarter and Nine-Month 2018 Financial Results,GlobeNewswire
Nov-15-18,Constellation Pharmaceuticals Highlights EZH2 Inhibition Program in Prostate Cancer at Biomedical Conference,GlobeNewswire
